


| Key | % Net Assets |
|---|---|
| 6.8% | |
| 5.7% | |
| 5.7% | |
| 4.9% | |
| 76.9% |
| Name | % Net Assets |
|---|---|
| BT | 6.8% |
| BP | 5.7% |
| GlaxoSmithKline | 5.7% |
| Rentokil Initial | 4.9% |
| BAE Systems | 4.9% |
| Imperial Tobacco | 4.6% |
| BG | 4.4% |
| AstraZeneca | 4.2% |
| Legal & General | 3.8% |
| Vodafone | 3.2% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 626.98p |
| Currency | GBP |
| Change | -0.35p |
| % | -0.06% |
| YTD change | 79.82p |
| YTD % | 14.59% |
| Fund Inception | 20/04/1988 |
|---|---|
| Fund Manager | Martin Walker |
| TER | 1.73 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | £100 |
| Savings | £20 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.72% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.11 |
You are here: research